drugset / Trial / NCT01318109
Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was evaluate the efficacy and safety of alogliptin, once dairy (QD) combined with metformin taken twice daily (BID) or three times daily (TID) in type 2 diabetic patients with uncontrolled blood glucose.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alogliptin | Unknown | 12.5 mg | Oral |
| Comparator | Alogliptin | Unknown | 25 mg | Oral |
| Comparator | Metformin | Small molecule | 250 mg | Oral |